Cardio Catch-Up: Two Studies Support Boston Scientific’s Subcutaneous ICD

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition covers the two clinical studies of Boston Scientific's Emblem MRI subcutaneous implantable cardioverter defibrillator.

Emlem S-ICD
Boston Scientific's Emblem S-ICD • Source: Boston Scientific

A secondary analysis of the 450-patient, randomized ATLAS trial suggests Boston Scientific's Emblem MRI subcutaneous implantable cardioverter defibrillator (S-ICD) can help prevent tricuspid valve regurgitation in arrhythmia patients.

Darryl Leong from McMaster University in Hamilton, Ontario presented the research at the Heart Rhythm 2023 conference in New...

More from Clinical Trials

More from R&D